Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.90−0.03 (-1.55%)
Close on Nov 17, 2026Market cap $18.96MP/E –Yield –
Atossa Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2015 it was -7431.9%, against 100.0% the year before. The highest annual figure on record is 100.0% in fiscal 2014.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | -7431.9% | −7531.9 |
| FY2014 | Dec 31, 2014 | 100.0% | +78.3 |
| FY2013 | Dec 31, 2013 | 21.7% | −64.7 |
| FY2012 | Dec 31, 2012 | 86.4% | +6465.7 |
| FY2011 | Dec 31, 2011 | -6379.3% | – |
See a number that looks wrong?